Loading…

Simultaneous diagnostic platform of genotyping EGFR, KRAS, and ALK in 510 Korean patients with non-small-cell lung cancer highlights significantly higher ALK rearrangement rate in advanced stage

Background Simultaneous genotyping has advantages in turnaround time and detecting the real mutational prevalence in unresectable non‐small‐cell lung cancer (NSCLC), a group not previously genetically characterized. Methods We developed simultaneous panel of screening EGFR and KRAS mutations by dire...

Full description

Saved in:
Bibliographic Details
Published in:Journal of surgical oncology 2014-09, Vol.110 (3), p.245-251
Main Authors: Kim, Tae-Jung, Park, Chan Kwon, Yeo, Chang Dong, Park, Kihoon, Rhee, Chin Kook, Kim, Jusang, Kim, Seung Joon, Lee, Sang Haak, Lee, Kyo-Young, Yoon, Hyoung-Kyu
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Simultaneous genotyping has advantages in turnaround time and detecting the real mutational prevalence in unresectable non‐small‐cell lung cancer (NSCLC), a group not previously genetically characterized. Methods We developed simultaneous panel of screening EGFR and KRAS mutations by direct sequencing or PNA clamping, and ALK rearrangement by fluorescent in situ hybridization (FISH) in multicenter manner. Results Of 510 NSCLC Korean patients, simultaneous genotyping identified mutations of EGFR (29.0%) and KRAS (8.6%) and rearrangement of ALK (9.2%). Seven patients had overlaps in mutations. Although several well‐known associations between genotypes and clinical characteristics were identified, we found no relationship between ALK rearrangement and sex or smoking history. Unlike the other genotype mutations, ALK rearrangement was associated with advanced disease. Among the ALK‐negative group, patients with 10–15% of ALK FISH split shared characteristics, such as younger age and advanced stage disease, more with the ALK‐positive group (>15% ALK FISH split) than
ISSN:0022-4790
1096-9098
DOI:10.1002/jso.23646